Fig. 3From: Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohortOverall survival analysis of high TMB (> 3.6 Mutations/Mb) and low TMB (≤ 3.6 Mutations/Mb).Back to article page